MEDNAX Inc (NYSE:MD) reported earnings of $1.07 per share meeting Walls Streets expectations.

ME Staff
-
0

MEDNAX Inc (NYSE:MD) reported Q2 2018 earnings this Morning, coming in at $1.07 per share, in-line Wall Street’s estimates of $1.07 per Share. Revenue for the quarter came in at $915.90 million beating analyst estimates of $911.77 million

Recent Insider Trading for MEDNAX Inc (NYSE:MD)

  • On 6/12/2018 John C. Pepia, Insider, sold 6,516 with an average share price of $46.56 per share and the total transaction amounting to $303,384.96.
  • On 6/12/2018 Vivian Lopez-Blanco, CFO, sold 13,942 with an average share price of $46.46 per share and the total transaction amounting to $647,745.32.
  • On 6/11/2018 Dominic J Andreano, SVP, sold 18,000 with an average share price of $46.95 per share and the total transaction amounting to $845,100.00.
  • On 6/1/2018 David A Clark, Insider, sold 11,607 with an average share price of $45.15 per share and the total transaction amounting to $524,056.05.
  • On 6/1/2018 Joseph M Calabro, COO, sold 22,186 with an average share price of $45.20 per share and the total transaction amounting to $1,002,807.20.
  • On 5/22/2018 John C Pepia, Insider, sold 3,000 with an average share price of $46.43 per share and the total transaction amounting to $139,290.00.



    About Company
    MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. The company also provides maternal-fetal care, including inpatient and office-based clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, its pediatric cardiology care services comprise inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it provides radiology and teleradiology services. As of December 31, 2017, the company's network consisted of approximately 4,075 affiliated physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

    Recent Analyst Rating for MEDNAX Inc (NYSE:MD)



      Recent Trading for MEDNAX Inc (NYSE:MD)
      Shares of MEDNAX Inc closed the previous trading session at 45.12 up +2.23 5.20% with 42.6 shares trading hands.